Josh Gottlieb
Papers
1
Total Citations
2
H-Index
1
About
Josh Gottlieb is a urologic oncologist whose research focuses on improving the characterization and treatment of prostate cancer, particularly through advanced surgical techniques and pathological staging. His major contributions center on refining the understanding of lymph node tumor burden in node-positive prostate cancer, a critical area where standard staging often falls short. In his highly cited 2023 work, Gottlieb investigated how the anatomical compartment of involved lymph nodes and the quantified extent of extranodal extension (ENE) correlate with biochemical recurrence-free survival (BRFS) following robotic-assisted radical prostatectomy with extended pelvic lymph node dissection. This research provides surgeons and oncologists with more granular prognostic tools, moving beyond simple nodal positivity to consider tumor burden distribution. With over 2 citations already, his work is gaining traction for its potential to personalize post-surgical surveillance and adjuvant therapy decisions. Gottlieb’s dedication to bridging surgical precision with oncologic outcomes positions him as an emerging leader in prostate cancer research, offering valuable insights for clinicians and researchers striving to improve survival and quality of life for patients with high-risk disease.
Research Focus
Key Achievements
Top Papers
- 1